KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $846M | $828M | $598M | $532M | $379M | $438M | $271M | $194M | $112M | $50M | $1.9M |
| Inventory | $46M | $40M | $27M | $7.0M | $0 | — | — | — | — | — | — |
| Current assets | $1.1B | $1.0B | $742M | $588M | $384M | $442M | $275M | $196M | $113M | $50M | $2.2M |
| Total assets | $1.5B | $1.3B | $1.1B | $818M | $558M | $626M | $311M | $209M | $116M | $50M | $2.2M |
| Current liabilities | $127M | $103M | $102M | $33M | $29M | $26M | $15M | $3.3M | $2.6M | $640K | $43K |
| Total liabilities | $142M | $114M | $109M | $40M | $36M | $33M | $19M | $6.1M | $2.9M | $640K | $1.9M |
| Shareholders' equity | $1.4B | $1.2B | $946M | $779M | $522M | $594M | $292M | $203M | $113M | $49M | $289K |
| Shares outstanding | 29.6M | 29.2M | 28.8M | 28.3M | 25.8M | 25.2M | 22.2M | 17.4M | — | 10.3M | — |
| Current ratio | 8.32 | 9.95 | 7.28 | 17.76 | 13.30 | 17.18 | 17.80 | 58.88 | 43.39 | 77.99 | 50.44 |